Vaxart reorganizes board committees; appoints new chairs effective Aug 1, 2026

Vaxart, Inc.

Kevin P. Finney appointed chair of Nominating and Governance Committee.
James B. Breitmeyer, M.D., Ph.D. appointed chair of Compensation Committee.
Committee memberships: Finney and Wheadon on Nominating; Breitmeyer, Heron, Watson on Compensation.
Reorganization effective August 1, 2026, approved by Board on July 27, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.